VAERS reports by lot

Moderna COVID-19 lot 003821A: VAERS reports

45 VAERS reports list lot 003821A as a Moderna COVID-19 vaccine, received between 2021-03-04 and 2023-07-25. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
45
Reports
16%
Marked serious
0
With a death outcome
12
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)5525%
Neurological4118%
Musculoskeletal2712%
Gastrointestinal2310%
Injection-site / Local reaction199%
Cardiac / Cardiovascular188%
Dermatological (non-injection-site)136%
Respiratory125%
Allergic / Anaphylactic52%
Psychiatric / Neuropsychiatric42%
Thrombotic / Hematological31%
Reproductive / Menstrual21%

Where reports came from

U.S. state of the reporter, where given (top 12).

Colorado6
Florida5
Arizona4
California3
Kansas3
Minnesota2
Indiana2
Ohio2
Tennessee2
Georgia2
Texas2
Virginia1

Reports by month received

2021-0311
2021-0414
2021-053
2021-073
2021-084
2021-092
2021-101
2021-112
2022-031
2022-041
2023-022
2023-071

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.